KT185

General

Type : Piperidine,Triazol

Chemical_Nomenclature : [3-[4-[1-(2-phenylpiperidine-1-carbonyl)triazol-4-yl]phenyl]phenyl]-piperidin-1-ylmethanone

Canonical SMILES : C1CCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(C=C3)C4=CN(N=N4)C(=O)N5CCCCC5C6=CC=CC=C6

InChI : InChI=1S\/C32H33N5O2\/c38-31(35-19-6-2-7-20-35)28-13-9-12-27(22-28)24-15-17-25(18-16-24)29-23-37(34-33-29)32(39)36-21-8-5-14-30(36)26-10-3-1-4-11-26\/h1,3-4,9-13,15-18,22-23,30H,2,5-8,14,19-21H2

InChIKey : SGQNTNACVSWXMA-UHFFFAOYSA-N

Other name(s) : KT-185,CHEMBL3263579,(2-Phenylpiperidin-1-yl)(4-(3'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone,BDBM50010336


MW : 519.6

Formula : C32H33N5O2

CAS_number : 1472640-86-0

PubChem : 53364498

UniChem : SGQNTNACVSWXMA-UHFFFAOYSA-N

Target

Families : KT185 ligand of proteins in family
ABHD6-Lip

Protein :
human-ABHD6

References (2)

Title : Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach - Choudhary_2020_Front.Immunol_11_1664
Author(s) : Choudhary S , Malik YS , Tomar S
Ref : Front Immunol , 11 :1664 , 2020
Abstract : Choudhary_2020_Front.Immunol_11_1664
ESTHER : Choudhary_2020_Front.Immunol_11_1664
PubMedSearch : Choudhary_2020_Front.Immunol_11_1664
PubMedID: 32754161

Title : Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of alpha\/beta-hydrolase domain containing 6 (ABHD6) - Hsu_2013_J.Med.Chem_56_8270
Author(s) : Hsu KL , Tsuboi K , Chang JW , Whitby LR , Speers AE , Pugh H , Cravatt BF
Ref : Journal of Medicinal Chemistry , 56 :8270 , 2013
Abstract : Hsu_2013_J.Med.Chem_56_8270
ESTHER : Hsu_2013_J.Med.Chem_56_8270
PubMedSearch : Hsu_2013_J.Med.Chem_56_8270
PubMedID: 24152295
Array
(
    [id] => 1899
    [inhibitor] => KT185
    [type] => Array
        (
            [0] => Piperidine
            [1] => Triazol
        )

    [other_name] => Array
        (
            [0] => KT-185
            [1] => CHEMBL3263579
            [2] => (2-Phenylpiperidin-1-yl)(4-(3'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-4-yl)-1H-1,2,3-triazol-1-yl)methanone
            [3] => BDBM50010336
        )

    [chemical_nomenclature] => [3-[4-[1-(2-phenylpiperidine-1-carbonyl)triazol-4-yl]phenyl]phenyl]-piperidin-1-ylmethanone
    [formula] => C32H33N5O2
    [cas_number] => 1472640-86-0
    [mw] => 519.6
    [pick_me_to_call] => display_script
    [kinetic_parameter] => 
    [paper] => Choudhary_2020_Front.Immunol_11_1664 || Hsu_2013_J.Med.Chem_56_8270
    [comment] => 
    [gene_locus] => human-ABHD6
    [kin_inhibitor] => 
    [cid] => 53364498
    [family] => ABHD6-Lip
    [inchikey] => SGQNTNACVSWXMA-UHFFFAOYSA-N
    [canonicalsmiles] => C1CCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(C=C3)C4=CN(N=N4)C(=O)N5CCCCC5C6=CC=CC=C6
    [inchi] => InChI=1S\/C32H33N5O2\/c38-31(35-19-6-2-7-20-35)28-13-9-12-27(22-28)24-15-17-25(18-16-24)29-23-37(34-33-29)32(39)36-21-8-5-14-30(36)26-10-3-1-4-11-26\/h1,3-4,9-13,15-18,22-23,30H,2,5-8,14,19-21H2
    [wikipedia] => 
    [iupharlig] => 
    [structure] => 
    [substrate] => 
    [interact_gene_locus] => 
    [mutation] => 
    [comment2] => 
    [extoxnet] => 
    [news] => 
    [theoretical_model] => 
)